首页> 美国卫生研究院文献>Pharmaceutics >Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery: Optimization of Cell Seeding by the Design of Experiment
【2h】

Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery: Optimization of Cell Seeding by the Design of Experiment

机译:用于间充质干细胞递送的丝/丝蛋白微载体:通过实验设计优化细胞接种

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this methodological paper, lyophilized fibroin-coated alginate microcarriers (LFAMs) proposed as mesenchymal stem cells (MSCs) delivery systems and optimal MSCs seeding conditions for cell adhesion rate and cell arrangement, was defined by a Design of Experiment (DoE) approach. Cells were co-incubated with microcarriers in a bioreactor for different time intervals and conditions: variable stirring speed, dynamic culture intermittent or continuous, and different volumes of cells-LFAMs loaded in the bioreactor. Intermittent dynamic culture resulted as the most determinant parameter; the volume of LFAMs/cells suspension and the speed used for the dynamic culture contributed as well, whereas time was a less influencing parameter. The optimized seeding conditions were: 98 min of incubation time, 12.3 RPM of speed, and 401.5 µL volume of cells-LFAMs suspension cultured with the intermittent dynamic condition. This DoE predicted protocol was then validated on both human Adipose-derived Stem Cells (hASCs) and human Bone Marrow Stem Cells (hBMSCs), revealing a good cell adhesion rate on the surface of the carriers. In conclusion, microcarriers can be used as cell delivery systems at the target site (by injection or arthroscopic technique), to maintain MSCs and their activity at the injured site for regenerative medicine.
机译:在该方法论论文中,通过实验设计(DoE)方法定义了冻干的纤维蛋白包被的藻酸盐微载体(LFAM)作为间充质干细胞(MSC)递送系统和最佳的MSCs接种条件,以实现细胞粘附率和细胞排列。将细胞与微载体在生物反应器中共同孵育不同的时间间隔和条件:可变的搅拌速度,间歇或连续的动态培养,以及在生物反应器中加载的不同体积的细胞-LFAM。间歇性动态文化是最决定性的参数。 LFAM /细胞悬浮液的体积和用于动态培养的速度也有所贡献,而时间是影响较小的参数。优化的接种条件为:孵育时间为98分钟,速度为12.3 RPM,并在间歇动态条件下培养401.5 µL细胞-LFAMs悬浮液。然后在人脂肪来源的干细胞(hASCs)和人骨髓干细胞(hBMSCs)上都验证了该DoE预测的方案,从而揭示了载体表面上良好的细胞粘附率。总之,微载体可以用作目标部位的细胞递送系统(通过注射或关节镜技术),以维持MSC及其在受损部位的活性,从而进行再生医学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号